Drug Trial Radar · NCT06953271
Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection
Last checked: Nov 19, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
164
Planned (sponsor's estimate)
Start
Aug 1, 2025
Primary completion
Jan 30, 2027
Study completion Apr 1, 2027
Sponsor
- Lead sponsor
- Women and Infants Hospital of Rhode IslandAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 1, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to compare methenamine hippurate prophylaxis to routine antibiotic prophylaxis following onabotulinumtoxinA (BOTOX-A) injections in women with overactive bladder (OAB). Participants will be randomly selected to receive one of the two post-procedural prophylaxis medications. The primary outcome measure will be urinary tract infection (UTI) rates within 30 days from the BOTOX-A procedure. Secondary outcomes will assess patient satisfaction with the two post-procedural prophylaxis medications.
Conditions
- Overactive Bladder (OAB)
- Urinary Tract Infection (Diagnosis)
Interventions
Methenamine HippurateDrug
Drug: Methenamine hippurate 1 gram by mouth twice daily for three days.
Typically prescribed oral antibiotic prophylaxisDrug
Drug: typically prescribed oral antibiotic prophylaxis following intradetrusor BOTOX-A injections. This includes, but is not limited to, antibiotic medications such as nitrofurantoin, amoxicillin/clavulanic acid, and trimethoprim/sulfamethoxazole. Dosage will be determined per usual care. Duration of treatment will be standardized to three days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Acute Urinary Tract InfectionTime frame: Date of the BOTOX-A injection to 30 days after the procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Women & Infants Hospital
Providence, Rhode Island · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.